--- title: 'Associate Director/Director, FP&A at Iambic Therapeutics, Inc' canonical: 'https://feeny.ai/job/associate-director-director-fp-a-iambic-therapeutics-inc-san-diego-z28z0y19xya6' type: 'job' last_seen: '2026-11-04' --- # Associate Director/Director, FP&A at Iambic Therapeutics, Inc - **Company:** Iambic Therapeutics, Inc - **Location:** San Diego, CA - **Employment:** full-time - **Work type:** hybrid - **Posted:** 2026-11-04 - **Last confirmed live:** 2026-11-04 - **Apply:** https://jobs.ashbyhq.com/iambic-therapeutics/23ca8483-b08d-48a4-a11b-bba6a224aca8 ## Job description ## JOB SUMMARY We are hiring an Associate Director / Director, FP&A to join the growing Finance Team at Iambic (Nasdaq: IAM), an innovative life sciences and technology company redefining drug discovery and development by applying industry-leading AI and Machine Learning technology. Reporting to the Sr Director, FP&A & Investor Relations, you will help own our budgeting and planning process, the consolidated financial model, and the long-range plan and cash runway scenarios. This is a high-ownership role on a lean , fast-paced team. It suits someone with strong financial modeling skills and business partnering experience who wants to help build and scale the Finance organization at a growing public biotech. This position will be based in our San Diego Headquarters, with exceptions for outstanding candidates to work remotely. ## RESPONSIBILITIES Budgeting and Planning Cycles - Serve as a finance business partner to Group leaders across the organization, including Computational, Discovery & Experimental, Clinical, and G&A, and project leaders for our partnership programs. - Lead our annual budgeting process supporting our Executive and Group leaders in establishing near-term Group budgets and our long-range plan across our portfolio of internal Pipeline assets, Partnership programs, and Platform initiatives. - Collaborate with Discovery R&D and Clinical Finance to lead our quarterly reporting process by providing Group leaders with key budget vs actuals analyses and working with them to update budget templates with the latest strategic and operational assumptions. Build and Maintain the Financial Models - Manage the consolidated three-statement financial models supporting our goal-based planning process, resource allocation, and strategic decision-making. - Maintain stage-based cost models tied to portfolio timelines and turn them into long-range plans across multiple scenarios. - Create detailed analyses and executive and Board-ready materials covering our financial performance and future outlook. - Support Business Development with program economics and deal modeling for partnerships. Scale Public Company Operations - Collaborate with the Accounting team on month-end close activities and financial reporting and Procurement on PO approvals and expense controls. - Support the development of scalable, gold-standard FP&A tools, systems and processes as the company grows. - Identify and recommend opportunities for process improvements and efficiency enhancements within the FP&A function. ## Team Development - Lead day-to-day FP&A operations, including planning and reporting timelines - Mentor and guide a team of high-performing colleagues across the FP&A team. ## QUALIFICATIONS Required - Bachelor’s degree in Accounting, Finance, Economics, or a related discipline preferred. Equivalent work experience will be considered; MBA and CFA a plus. - 8+ years of professional experience in FP&A within biotech, pharma or life sciences, and/or investment banking, consulting or corporate development with a healthcare or life sciences focus. - Demonstrated expertise building and running complex three-statement, multi-scenario financial models. - Several years as a finance business partner in an operating company, ideally in biotech or life sciences with proven ability to collaborate with executives and department heads, including scientific leaders, on budgets, tradeoffs and resource allocation. - Experience managing and developing finance professionals, including hiring. - Experience leading recurring planning and reporting cycles on tight timelines, in close partnership with Accounting. - Familiarity with drug development economics (program-level costs, development stages, partnership structures) strongly preferred. - Public-company experience, such as earnings preparation, SEC filing support or investor materials preferred. - Experience with Adaptive Planning (or a similar planning tool) and NetSuite (or a similar ERP) preferred. ## ABOUT IAMBIC THERAPEUTICS Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with unprecedented speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets, both internally and in partnership, to address urgent unmet patient need. Learn more about the Iambic team, platform, pipeline, and partnerships at [iambic.ai](http://iambic.ai). ## MISSION & CORE VALUES Our mission is to deliver better medicines through innovations in AI-based discovery technologies. The culture and work at Iambic Therapeutics are profoundly strengthened by the diversity of our people and our differences in background, culture, national origin, religion, sexual orientation, and life experiences. We are committed to building an inclusive environment where a diverse group of talented humans work together to discover therapeutics and create technologies. ## PAY AND BENEFITS We offer industry leading competitive pay, company paid healthcare, flexible spending accounts, voluntary life insurance, 401K matching, and uncapped vacation to our team. We are in a brand-new state-of-the art facility in beautiful San Diego with an onsite gym, dining, and easy access to great places to live and play. ## About Iambic Therapeutics, Inc ## Company Overview - **One-liner**: Iambic Therapeutics is a clinical‑stage biotechnology company that uses an AI‑driven platform to discover and develop novel small‑molecule medicines for oncology and other diseases. - **Entity Type**: Private (late‑stage venture‑backed) - **Headquarters**: San Diego, California, United States - **Founded**: 2020 - **Founders**: Not explicitly named in available sources; leadership includes a Co‑Founder & CEO and a Co‑Founder & CTO. ## Core Business - **Primary industries**: Biotechnology, AI‑powered drug discovery, oncology therapeutics - **Target customers**: B2B partnerships with pharmaceutical companies (e.g., Bayer) and, ultimately, patients through a wholly‑owned pipeline of clinical‑stage candidates - **Mission**: *“Better technology for better medicines”* – using machine learning and automation to transform the creation of new therapeutics ## Products & Services - **Enchant Platform**: A multi‑modal transformer AI that breaks down data barriers between preclinical and clinical R&D, enabling rapid molecular design. - **NeuralPLexer**: A co‑folding AI technology that predicts protein‑ligand structures to guide drug design. - **Automated High‑Throughput Experimentation**: AI‑driven robotics that generate new biological data from novel molecular designs on a weekly cadence. - **IAM1363** (HER2 inhibitor): A highly selective, brain‑penetrant tyrosine kinase inhibitor for HER2‑driven cancers; currently in Phase 1b clinical studies. - **IAM‑C1** (CDK2/4 dual inhibitor): A potential first‑in‑class selective inhibitor for HR+/HER2‑ metastatic breast cancer (preclinical). - **IAM‑K1** (KIF18A inhibitor): A potential best‑in‑class allosteric inhibitor for triple‑negative breast cancer, ovarian cancer, and other solid tumors (preclinical). - **Undisclosed programs**: Additional wholly‑owned candidates across multiple target classes and mechanisms. ## Market Standing - **Valuation**: Not publicly disclosed - **Key Metric**: **Total funding** – $330.8 M (including a $100 M Series B in Oct 2023, a $50 M Series B extension in Apr 2024 led by EXOR N.V. and Mubadala Capital, and a $127.8 M venture round in Nov 2025) - **Notable Investors/Partners**: EXOR N.V., Mubadala Capital, Nexus Venture, Bayer (collaboration in AI drug discovery), and a Scientific Advisory Board including Nobel Laureate Frances Arnold (Caltech) - **Growth Signals**: - Headcount of **117** (64.5 % year‑over‑year growth) - Active job postings: **18** (+200 % quarterly, +50 % yearly) - Pipeline advanced from program launch to IND in **2 years** (vs. 6‑year industry average for IAM1363) - Broad platform applicability demonstrated across orthosteric, allosteric, and protein‑protein interaction modalities ## Competitive Advantages - **Speed**: AI‑driven platform can deliver development candidates to clinical trials in roughly one‑third the industry average time. - **Selectivity & Differentiated Profiles**: IAM1363 shows > 5000‑fold selectivity against EGFR, avoiding EGFR‑driven toxicity; IAM‑C1 targets CDK2/4 with a novel selectivity profile. - **Broad Platform Applicability**: Platform has produced leads across diverse protein classes and mechanisms (orthosteric, allosteric, PPI modulators). - **Integration of AI and Drug Hunting**: Tightly integrated team of AI experts and seasoned drug hunters, with a culture of “audacity” that tackles hard chemistry problems. ## Strategic Focus - Advancing the clinical pipeline: IAM1363 Phase 1b, preparing IAM‑C1 and IAM‑K1 for IND‑enabling studies. - Expanding platform partnerships (e.g., Bayer collaboration). - Scaling the organization: actively hiring in ML science, computational chemistry, medicinal chemistry, and clinical operations. - Exploring new therapeutic areas and target classes through the Enchant and NeuralPLexer technologies. ## Why Work Here - **Culture**: Values of **Respect**, **Collaboration**, and **Audacity** – cross‑functional teamwork with resilience and optimism; a flat, high‑trust environment. - **Work Model**: Based in La Jolla/San Diego, CA; the company emphasizes on‑site collaboration for drug‑discovery and lab‑based roles; remote/hybrid policy not explicitly stated. - **Team Growth**: Rapidly scaling (headcount +64 % YoY) with a strong pipeline of open roles in ML, computational chemistry, drug product development, and clinical operations. - **Cutting‑Edge Work**: Opportunity to work at the intersection of frontier AI (large multimodal models, agentic data pipelines) and real‑world drug discovery that reaches patients. - **Leadership & Mentorship**: Advisory board includes Nobel laureate and former NVIDIA AI director; close integration of AI and biology. ## Sources 1. [iambic.ai](https://www.iambic.ai/) – Homepage, platform, and corporate overview 2. [iambic.ai/about](https://www.iambic.ai/about) – Leadership, advisory board, investors 3. [iambic.ai/pipeline](https://www.iambic.ai/pipeline) – Pipeline details (IAM1363, IAM‑C1, IAM‑K1) 4. [iambic.ai/careers](https://www.iambic.ai/careers) – Careers page, values, open positions 5. [linkedin.com/company/iambic-ai](https://www.linkedin.com/company/iambic-ai) – Company stats (headcount 117, $3.4M revenue, $330.8M funding, funding rounds, employee growth) ## Other roles at Iambic Therapeutics, Inc - [Sr Manager, FP&A - Discovery R&D](https://feeny.ai/job/sr-manager-fp-a-discovery-r-d-iambic-therapeutics-inc-san-diego-sznt8xkbx741) — San Diego, CA - [Director, IP Counsel](https://feeny.ai/job/director-ip-counsel-iambic-therapeutics-inc-san-diego-492xa6xt2p79) — San Diego, CA - [Corporate Counsel, Commercial](https://feeny.ai/job/corporate-counsel-commercial-iambic-therapeutics-inc-san-diego-ww25hgtsp3t5) — San Diego, CA - [IT Support Specialist](https://feeny.ai/job/it-support-specialist-iambic-therapeutics-inc-san-diego-g98wd14jdssg) — San Diego, CA - [Sr. Project Manager, Clinical Development](https://feeny.ai/job/sr-project-manager-clinical-development-iambic-therapeutics-inc-san-diego-ypkbzp0zb86s) — San Diego, CA - [Sr Associate Scientist I or II, Medicinal Chemistry](https://feeny.ai/job/sr-associate-scientist-i-or-ii-medicinal-chemistry-iambic-therapeutics-inc-san-7zek78ek4h8y) — San Diego, CA - [Principal Scientist, Medicinal Chemistry](https://feeny.ai/job/principal-scientist-medicinal-chemistry-iambic-therapeutics-inc-san-diego-et7kjjyvc1yv) — San Diego, CA - [Principal / AD / Director, Agentic AI](https://feeny.ai/job/principal-ad-director-agentic-ai-iambic-therapeutics-inc-san-diego-1g1gksks4q51) — San Diego, CA - [Software Engineer I/II - Scientific Computing](https://feeny.ai/job/software-engineer-i-ii-scientific-computing-iambic-therapeutics-inc-boston-2vn970jxspag) — Boston, MA - [Sr. Associate Scientist I / II – High Throughput Chemistry](https://feeny.ai/job/sr-associate-scientist-i-ii-high-throughput-chemistry-iambic-therapeutics-inc-41r8p5392c9w) — San Diego, CA